sarpogrelate has been researched along with transforming growth factor beta in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anami, Y; Kasho, M; Kobori, S; Matsuda, H; Matsumura, T; Sakai, M; Sasahara, T; Shichiri, M; Takemura, T | 1 |
| Kariyazono, H; Masuda, H; Nakamura, K; Sakata, R; Yamada, K | 1 |
| Asakura, H; Hayashi, T; Morishita, E; Nakao, S; Ontachi, Y; Yamazaki, M; Yoshida, T | 1 |
| Choi, HS; Jun, DW; Kim, DC; Kim, EK; Kwon, YI; Lee, HL; Lee, KN; Lee, OY; Yoon, BC | 1 |
1 trial(s) available for sarpogrelate and transforming growth factor beta
| Article | Year |
|---|---|
Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans.
Topics: Adenosine Diphosphate; Aged; Arteriosclerosis Obliterans; Case-Control Studies; Collagen; Female; Humans; Linear Models; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; Serotonin Antagonists; Succinates; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
3 other study(ies) available for sarpogrelate and transforming growth factor beta
| Article | Year |
|---|---|
Serotonin enhances the production of type IV collagen by human mesangial cells.
Topics: Cells, Cultured; Collagen; Diabetic Nephropathies; Glomerular Mesangium; Humans; Ketanserin; Kinetics; Protein Kinase C; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Serotonin; Serotonin Antagonists; Succinates; Transforming Growth Factor beta | 1998 |
Effects of sarpogrelate hydrochloride in a patient with chronic graft-versus-host disease: a case report.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; Humans; Male; Receptors, Platelet-Derived Growth Factor; Serotonin Antagonists; Succinates; Transforming Growth Factor beta | 2006 |
5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis.
Topics: Actins; Animals; Apoptosis; Cell Line; Cell Survival; Collagen Type I; Dose-Response Relationship, Drug; Hepatic Stellate Cells; Humans; Ketanserin; Liver Cirrhosis, Experimental; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Serotonin, 5-HT2A; Ritanserin; RNA, Messenger; Serotonin 5-HT2 Receptor Antagonists; Smad2 Protein; Smad3 Protein; Succinates; Thioacetamide; Time Factors; Transforming Growth Factor beta; Wound Healing | 2013 |